Maurizio Corbetta
Overview
Explore the profile of Maurizio Corbetta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
259
Citations
25238
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alves P, Nozais V, Hansen J, Corbetta M, Nachev P, Martins I, et al.
Nat Commun
. 2025 Mar;
16(1):2555.
PMID: 40089467
Distinctive patterns of brain neurotransmission frame determinant circuits for behavior. Understanding the relationship between their damage and the cognitive impairment provoked by brain lesions could provide insights into the pathophysiology...
2.
Pini L, Brusini L, Griffa A, Cruciani F, Allali G, Frisoni G, et al.
Neurobiol Dis
. 2025 Mar;
208:106866.
PMID: 40081429
Alzheimer's disease (AD) can be conceptualized as a network-based syndrome. Network alterations are linked to the molecular hallmarks of AD, involving amyloid-beta and tau accumulation, and consecutively neurodegeneration. By combining...
3.
Zhang L, Pini L, Shulman G, Corbetta M
Proc Natl Acad Sci U S A
. 2025 Mar;
122(11):e2415508122.
PMID: 40073058
Resting brain activity, in the absence of explicit tasks, appears as distributed spatiotemporal patterns that reflect structural connectivity and correlate with behavioral traits. However, its role in shaping behavior remains...
4.
Rocha R, Zorzi M, Corbetta M
Sci Rep
. 2024 Dec;
14(1):31631.
PMID: 39738232
Can focal brain lesions, such as those caused by stroke, disrupt critical brain dynamics? What biological mechanisms drive its recovery? In a recent study, we showed that focal lesions generate...
5.
Advanced disconnectomic analyses reveal repetition pathways in a case of mixed transcortical aphasia
Bellin I, Menardi A, De Pellegrin S, Bisogno A, Semenza C, Corbetta M, et al.
Brain Cogn
. 2024 Dec;
183():106257.
PMID: 39732053
Mixed Transcortical Aphasia (MTA) is an infrequent aphasic syndrome, characterized by poor comprehension and production in oral language abilities and poor performance in written language abilities. However, individuals with MTA...
6.
Sansone G, Lombardi G, Maccari M, Gaiola M, Pini L, Cerretti G, et al.
Brain Commun
. 2024 Dec;
6(6):fcae415.
PMID: 39713243
A large literature assessed the relationships between the O-methylguanine-DNA methyltransferase (MGMT) promoter methylation status and glioblastoma location with inconsistent results. Studies assessing this association using the percentage of methylation are...
7.
Vallini G, Silvestri E, Volpi T, Lee J, Vlassenko A, Goyal M, et al.
Eur J Nucl Med Mol Imaging
. 2024 Oct;
52(3):836-850.
PMID: 39472368
Purpose: This study evaluates the potential of within-individual Metabolic Connectivity (wi-MC), from dynamic [F]FDG PET data, based on the Euclidean Similarity method. This approach leverages the biological information of the...
8.
Matsulevits A, Coupe P, Nguyen H, Talozzi L, Foulon C, Nachev P, et al.
Brain Commun
. 2024 Oct;
6(5):fcae338.
PMID: 39464219
This study investigates the efficacy of deep-learning models in expediting the generation of disconnectomes for individualized prediction of neuropsychological outcomes one year after stroke. Utilising a 3D U-Net network, we...
9.
Matsulevits A, Alvez P, Atzori M, Beyh A, Corbetta M, Pup F, et al.
bioRxiv
. 2024 Oct;
PMID: 39464108
Stroke remains a leading cause of mortality and long-term disability worldwide, with variable recovery trajectories posing substantial challenges in anticipating post-event care and rehabilitation planning. To address these challenges, we...
10.
Musso G, Gabelli C, Puthenparampil M, Cosma C, Cagnin A, Gallo P, et al.
Clin Chim Acta
. 2024 Oct;
565:120014.
PMID: 39442787
Background: Advances in analytical methods have recently paved the way to Alzheimer's disease (AD) biomarkers testing in blood along with the more established CSF testing. To ensure a forthcoming application...